Patients take sodium valproate, usually for the treatment of epilepsy. Sodium valproate is a broad-spectrum antiepileptic drug. This drug is not dependent and discontinuation does not lead to withdrawal reactions or withdrawal reactions. However, if a patient’s epilepsy is not cured, discontinuing sodium valproate may lead to a recurrence of epilepsy and, in the case of poorly controlled epilepsy, may induce frequent seizures or persistent status epilepticus. The latter is one of the most serious neurological disorders in which patients tend to sustain convulsions for more than 5 minutes or have repeated convulsions, but the level of consciousness fails to return to normal between the 2 convulsions. This condition can lead to ischemia and hypoxia of the whole body organs, especially the brain and important organs such as the heart, liver, lungs and kidneys, and can induce multiple organ failure, which can cause hyperthermia and coma, and can directly lead to the patient’s death in severe cases.